Jianxin Capital is focused on healthcare industry risk investment fund.
Shanghai Jianxin equity is a Cci Capital Ltd focused on healthcare industry risk investment fund, has a professional investment team, the team has rich medical and financial investment, management and entrepreneurial experience, can make prospective investment layout according to the development trend of the industry, creating value for enterprises and investors. The company has a team of nearly 20 professional investment team, they were from medical institutions and financial class at home and abroad, with senior biomedical and financial professional background, have rich human resources in the field, the trend of development, familiar with domestic and international bio pharmaceutical industry research and development dynamics, can focus on the invested enterprise demand for product development, industrialization, management and financial investment and a full range of value-added services.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 26, 2020
GeneCast Biotechnology
|
Series E | — | Biotechnology | — |